Mind Medicine (MindMed) Inc. (MNMD) Earnings History
Net Loss11 years of earnings data (2015–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Mind Medicine (MindMed) Inc. (MNMD) Earnings Overview
As of June 21, 2026, Mind Medicine (MindMed) Inc. (MNMD) reported trailing twelve-month net income of -$238M, reflecting -1273.3% year-over-year growth. The company earned $-2.18 per diluted share over the past four quarters.
Looking at the long-term picture, MNMD's historical earnings data spans multiple years. The company achieved its highest annual net income of -$92,656 in fiscal 2015.
Mind Medicine (MindMed) Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$179M net income), ATAI (-$663M net income, -16142.0% margin), CYBN (-$123M net income), MNMD has comparable earnings metrics. Compare MNMD vs CMPS →
MNMD Earnings vs Peers
Earnings metrics vs comparable public companies
MNMD Historical Earnings Data (2015–2025)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$184M | -69.1% | -$166M | $-2.06 | - | - |
| 2024 | -$109M | -13.5% | -$104M | $-0.15 | - | - |
| 2023 | -$96M | -68.6% | -$94M | $-2.44 | - | - |
| 2022 | -$57M | +39.0% | -$66M | $-1.84 | - | - |
| 2021 | -$93M | -172.8% | -$94M | $-3.40 | - | - |
| 2020 | -$34M | -2956.2% | -$33M | $-1.92 | - | - |
| 2019 | -$1M | -30.1% | $-468,180 | $-2.94 | - | - |
| 2018 | $-857,944 | +30.1% | $-861,940 | $-2.74 | - | - |
| 2017 | -$1M | -581.9% | -$1M | $-4.85 | - | - |
| 2016 | $-179,900 | -94.2% | $-111,250 | $-2.24 | - | - |
| 2015 | $-92,656 | - | $-94,550 | $-1.17 | - | - |
Download Data
Export MNMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MNMD — Frequently Asked Questions
Quick answers to the most common questions about buying MNMD stock.
What is MNMD earnings per share (EPS)?
MNMD trailing twelve-month (TTM) diluted EPS is $-2.18, reflecting -1273.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2015 to 2025 is available in the table on this page.
What is Mind Medicine (MindMed) Inc.'s net income?
Mind Medicine (MindMed) Inc. (MNMD) trailing twelve-month net income is $-238M as of 2025. Earnings declined -1273.3% year-over-year.
Is MNMD profitable?
MNMD is not currently profitable on a TTM basis, reporting a net loss of $-238M. Net margin is N/A. Investors should monitor for a return to profitability.
What is MNMD's earnings growth rate?
MNMD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2015 to 2025.
What are MNMD's profit margins?
Mind Medicine (MindMed) Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -64.1%.
Is MNMD growing earnings?
MNMD earnings are declining — EPS fell -1273.3% year-over-year. TTM net income dropped to $-238M. This contrasts with the 5-year CAGR of N/A.
What was MNMD's best earnings year?
Mind Medicine (MindMed) Inc.'s highest annual net income on record is $-92656.00, achieved in fiscal year 2015. Earnings history on this page spans 2015 to 2025 and includes all annual and quarterly figures.
What were MNMD's earnings last quarter?
MNMD's most recent reported quarter was Q1 2026. Net income was $-77M with diluted EPS of $-0.71. For a full breakdown of all quarters, see the quarterly earnings table on this page.